Production (Stage)
Tectonic Therapeutic, Inc.
TECX
$21.65
-$0.55-2.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.55% | 30.16% | -39.82% | 16.75% | -93.43% |
| Total Depreciation and Amortization | -29.13% | 19.81% | 26.19% | -10.88% | 1.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 303.40% | -66.91% | -12.55% | -16.77% | 757.70% |
| Change in Net Operating Assets | 97.31% | -31.27% | -29.91% | -214.06% | 176.79% |
| Cash from Operations | 22.22% | 14.20% | -46.50% | -44.31% | 20.45% |
| Capital Expenditure | -800.00% | 98.04% | -3,925.00% | 200.00% | 92.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -800.00% | 98.04% | -3,925.00% | 200.00% | 92.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.61% | 4.17% | 1.64% | -3.39% | -2.61% |
| Issuance of Common Stock | -- | -- | -99.92% | 2,431,000.00% | -99.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 102.35% | -107.56% | 15,012.64% | -- |
| Cash from Financing | 16,762.49% | 83.00% | -103.50% | 27,006.89% | -101.96% |
| Foreign Exchange rate Adjustments | -113.51% | 146.67% | -6.25% | 121.05% | -575.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,024.10% | 31.40% | -115.64% | 1,760.27% | -144.66% |